Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens

BACKGROUND & AIMS: Daclatasvir has achieved high sustained virologic response (SVR) rates in diverse hepatitis C virus (HCV) populations. This study evaluated the long‐term efficacy and safety of daclatasvir‐based regimens administered during clinical studies. METHODS: Patients enrolled within 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, K. Rajender, Pol, Stanislas, Thuluvath, Paul J., Kumada, Hiromitsu, Toyota, Joji, Chayama, Kazuaki, Levin, James, Lawitz, Eric J., Gadano, Adrian, Ghesquiere, Wayne, Gerken, Guido, Brunetto, Maurizia R., Peng, Cheng‐Yuan, Silva, Marcelo, Strasser, Simone I., Heo, Jeong, McPhee, Fiona, Liu, Zhaohui, Yang, Rong, Linaberry, Misti, Noviello, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947593/
https://www.ncbi.nlm.nih.gov/pubmed/28941023
http://dx.doi.org/10.1111/liv.13596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947593/
https://www.ncbi.nlm.nih.gov/pubmed/28941023
http://dx.doi.org/10.1111/liv.13596

Ejemplares similares